Athersys begins clinical trials for MultiStem cell therapy for COVID-19,

May 5, 2020 — Athersys announced that it has begun enrollment in its phase 2/3 study named “MultiStem Administration for COVID-19 Induced Acute …, May 5, 2020 — Athersys announced that it has begun enrollment in its phase 2/3 study named “MultiStem Administration for COVID-19 Induced Acute …, Read More

Scroll to Top